List of Tables
Table 1. Global Neurodegenerative Disease Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of NMDA
Table 3. Key Players of SSRIs
Table 4. Key Players of Dopamine Inhibitors
Table 5. Global Neurodegenerative Disease Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Neurodegenerative Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Neurodegenerative Disease Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Neurodegenerative Disease Market Share by Region (2019-2024)
Table 9. Global Neurodegenerative Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Neurodegenerative Disease Market Share by Region (2025-2030)
Table 11. Neurodegenerative Disease Market Trends
Table 12. Neurodegenerative Disease Market Drivers
Table 13. Neurodegenerative Disease Market Challenges
Table 14. Neurodegenerative Disease Market Restraints
Table 15. Global Neurodegenerative Disease Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Neurodegenerative Disease Revenue Share by Players (2019-2024)
Table 17. Global Top Neurodegenerative Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease as of 2023)
Table 18. Global Neurodegenerative Disease Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Neurodegenerative Disease Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Neurodegenerative Disease, Headquarters and Area Served
Table 21. Global Key Players of Neurodegenerative Disease, Product and Application
Table 22. Global Key Players of Neurodegenerative Disease, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Neurodegenerative Disease Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Neurodegenerative Disease Revenue Market Share by Type (2019-2024)
Table 26. Global Neurodegenerative Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Neurodegenerative Disease Revenue Market Share by Type (2025-2030)
Table 28. Global Neurodegenerative Disease Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Neurodegenerative Disease Revenue Share by Application (2019-2024)
Table 30. Global Neurodegenerative Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Neurodegenerative Disease Revenue Share by Application (2025-2030)
Table 32. North America Neurodegenerative Disease Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Neurodegenerative Disease Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Neurodegenerative Disease Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Neurodegenerative Disease Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Neurodegenerative Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Neurodegenerative Disease Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Neurodegenerative Disease Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Neurodegenerative Disease Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Neurodegenerative Disease Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Neurodegenerative Disease Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Neurodegenerative Disease Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Neurodegenerative Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Neurodegenerative Disease Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Neurodegenerative Disease Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Neurodegenerative Disease Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Neurodegenerative Disease Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Neurodegenerative Disease Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Neurodegenerative Disease Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Neurodegenerative Disease Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Neurodegenerative Disease Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Neurodegenerative Disease Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Neurodegenerative Disease Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Neurodegenerative Disease Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Neurodegenerative Disease Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Neurodegenerative Disease Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Neurodegenerative Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Country (2025-2030) & (US$ Million)
Table 64. Novartis Company Details
Table 65. Novartis Business Overview
Table 66. Novartis Neurodegenerative Disease Product
Table 67. Novartis Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 68. Novartis Recent Developments
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Neurodegenerative Disease Product
Table 72. Pfizer Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 73. Pfizer Recent Developments
Table 74. Merck Serono Company Details
Table 75. Merck Serono Business Overview
Table 76. Merck Serono Neurodegenerative Disease Product
Table 77. Merck Serono Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 78. Merck Serono Recent Developments
Table 79. Biogen Idec Company Details
Table 80. Biogen Idec Business Overview
Table 81. Biogen Idec Neurodegenerative Disease Product
Table 82. Biogen Idec Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 83. Biogen Idec Recent Developments
Table 84. TEVA Company Details
Table 85. TEVA Business Overview
Table 86. TEVA Neurodegenerative Disease Product
Table 87. TEVA Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 88. TEVA Recent Developments
Table 89. UCB Company Details
Table 90. UCB Business Overview
Table 91. UCB Neurodegenerative Disease Product
Table 92. UCB Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 93. UCB Recent Developments
Table 94. Boehringer Ingelheim Company Details
Table 95. Boehringer Ingelheim Business Overview
Table 96. Boehringer Ingelheim Neurodegenerative Disease Product
Table 97. Boehringer Ingelheim Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 98. Boehringer Ingelheim Recent Developments
Table 99. Sanofi Company Details
Table 100. Sanofi Business Overview
Table 101. Sanofi Neurodegenerative Disease Product
Table 102. Sanofi Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 103. Sanofi Recent Developments
Table 104. GlaxoSmithKline Company Details
Table 105. GlaxoSmithKline Business Overview
Table 106. GlaxoSmithKline Neurodegenerative Disease Product
Table 107. GlaxoSmithKline Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 108. GlaxoSmithKline Recent Developments
Table 109. Livzon Pharmaceutical Company Details
Table 110. Livzon Pharmaceutical Business Overview
Table 111. Livzon Pharmaceutical Neurodegenerative Disease Product
Table 112. Livzon Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 113. Livzon Pharmaceutical Recent Developments
Table 114. Haisco Pharmaceutical Company Details
Table 115. Haisco Pharmaceutical Business Overview
Table 116. Haisco Pharmaceutical Neurodegenerative Disease Product
Table 117. Haisco Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 118. Haisco Pharmaceutical Recent Developments
Table 119. Jingxin Pharmaceutical Company Details
Table 120. Jingxin Pharmaceutical Business Overview
Table 121. Jingxin Pharmaceutical Neurodegenerative Disease Product
Table 122. Jingxin Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 123. Jingxin Pharmaceutical Recent Developments
Table 124. Dongcheng Biochemicals Company Details
Table 125. Dongcheng Biochemicals Business Overview
Table 126. Dongcheng Biochemicals Neurodegenerative Disease Product
Table 127. Dongcheng Biochemicals Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 128. Dongcheng Biochemicals Recent Developments
Table 129. Hisun Pharmaceutical Company Details
Table 130. Hisun Pharmaceutical Business Overview
Table 131. Hisun Pharmaceutical Neurodegenerative Disease Product
Table 132. Hisun Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 133. Hisun Pharmaceutical Recent Developments
Table 134. Luye Pharma Company Details
Table 135. Luye Pharma Business Overview
Table 136. Luye Pharma Neurodegenerative Disease Product
Table 137. Luye Pharma Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 138. Luye Pharma Recent Developments
Table 139. Ark Pharmaceutical Company Details
Table 140. Ark Pharmaceutical Business Overview
Table 141. Ark Pharmaceutical Neurodegenerative Disease Product
Table 142. Ark Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 143. Ark Pharmaceutical Recent Developments
Table 144. Kanghong Pharmaceutical Company Details
Table 145. Kanghong Pharmaceutical Business Overview
Table 146. Kanghong Pharmaceutical Neurodegenerative Disease Product
Table 147. Kanghong Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 148. Kanghong Pharmaceutical Recent Developments
Table 149. Huahai Pharmaceutical Company Details
Table 150. Huahai Pharmaceutical Business Overview
Table 151. Huahai Pharmaceutical Neurodegenerative Disease Product
Table 152. Huahai Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 153. Huahai Pharmaceutical Recent Developments
Table 154. BORA PHARMACEUTICALS Company Details
Table 155. BORA PHARMACEUTICALS Business Overview
Table 156. BORA PHARMACEUTICALS Neurodegenerative Disease Product
Table 157. BORA PHARMACEUTICALS Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
Table 158. BORA PHARMACEUTICALS Recent Developments
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurodegenerative Disease Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Neurodegenerative Disease Market Share by Type: 2023 VS 2030
Figure 3. NMDA Features
Figure 4. SSRIs Features
Figure 5. Dopamine Inhibitors Features
Figure 6. Global Neurodegenerative Disease Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Neurodegenerative Disease Market Share by Application: 2023 VS 2030
Figure 8. Parkinson’s Disease Case Studies
Figure 9. Huntington Disease Case Studies
Figure 10. Amyotrophic Lateral Sclerosis Case Studies
Figure 11. Alzheimer’s Disease Case Studies
Figure 12. Neurodegenerative Disease Report Years Considered
Figure 13. Global Neurodegenerative Disease Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Neurodegenerative Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Neurodegenerative Disease Market Share by Region: 2023 VS 2030
Figure 16. Global Neurodegenerative Disease Market Share by Players in 2023
Figure 17. Global Top Neurodegenerative Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Neurodegenerative Disease Revenue in 2023
Figure 19. North America Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Neurodegenerative Disease Market Share by Type (2019-2030)
Figure 21. North America Neurodegenerative Disease Market Share by Application (2019-2030)
Figure 22. North America Neurodegenerative Disease Market Share by Country (2019-2030)
Figure 23. United States Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Neurodegenerative Disease Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Neurodegenerative Disease Market Share by Type (2019-2030)
Figure 27. Europe Neurodegenerative Disease Market Share by Application (2019-2030)
Figure 28. Europe Neurodegenerative Disease Market Share by Country (2019-2030)
Figure 29. Germany Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Neurodegenerative Disease Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Neurodegenerative Disease Market Share by Type (2019-2030)
Figure 37. China Neurodegenerative Disease Market Share by Application (2019-2030)
Figure 38. Asia Neurodegenerative Disease Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Neurodegenerative Disease Market Share by Type (2019-2030)
Figure 40. Asia Neurodegenerative Disease Market Share by Application (2019-2030)
Figure 41. Asia Neurodegenerative Disease Market Share by Region (2019-2030)
Figure 42. Japan Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Neurodegenerative Disease Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Neurodegenerative Disease Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Neurodegenerative Disease Market Share by Country (2019-2030)
Figure 52. Brazil Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Novartis Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 59. Pfizer Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 60. Merck Serono Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 61. Biogen Idec Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 62. TEVA Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 63. UCB Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 65. Sanofi Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 66. GlaxoSmithKline Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 67. Livzon Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 68. Haisco Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 69. Jingxin Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 70. Dongcheng Biochemicals Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 71. Hisun Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 72. Luye Pharma Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 73. Ark Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 74. Kanghong Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 75. Huahai Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 76. BORA PHARMACEUTICALS Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed